Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BWA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,859
Award facts
- Contract value 100% obligated
- $12,858.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,858.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 19, 2025, with completion scheduled for December 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for global pharmaceutical support across the Department of Defense. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp maintains a substantial federal contracting portfolio supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The Dupixent supply under this delivery order supports the broader pharmaceutical prime vendor program, which provides flexible procurement capabilities for the Defense Health Agency and other government healthcare entities. AmerisourceBergen's ability to secure consistent delivery orders under its large IDC demonstrates its established capability to meet federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9BWA?
SPE2DR26F9BWA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9BWA worth?
The government has obligated $12,859 on SPE2DR26F9BWA.
Is contract SPE2DR26F9BWA an order under another contract?
Yes. SPE2DR26F9BWA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BWA competed?
The extent of competition for SPE2DR26F9BWA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award